Literature DB >> 18231801

Expression of epidermal growth factor receptor in the inverted papilloma and squamous cell carcinoma of nasal cavity.

Jiung-Chih Chao1, Sheen-Yie Fang.   

Abstract

The present study was undertaken to compare positive rate of immunostaining (PR) and positive intensity of immunostaining (PI) of epidermal growth factor receptor (EGFR) in inverted papilloma (IP), synchronous carcinoma with IP and metachronous carcinoma with IP of the nasal cavity. Ten subjects with nasal polyps, ten subjects with inverted papilloma (IP), five subjects with synchronous carcinoma with IP and ten subjects with metachronous carcinoma with IP were enrolled with a control group of ten subjects of inferior turbinate. Each specimen was divided into two portions: one for RNA isolation and the other for detection of EGFR protein. Positive rate of immunostaining, positive intensity of immunostaining for EGFR protein and EGFR mRNA were significantly up-regulated in the IP, synchronous carcinoma with IP and metachronous carcinoma with IP when comparing polyp and normal mucosa. A role for EGFR in the malignant transformation from IP to SCC of the nasal cavity is suggested.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18231801     DOI: 10.1007/s00405-008-0582-3

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  29 in total

1.  Differential expression of epidermal growth factor receptor in human head and neck cancers.

Authors:  L D Ke; K Adler-Storthz; G L Clayman; A W Yung; Z Chen
Journal:  Head Neck       Date:  1998-07       Impact factor: 3.147

Review 2.  Targeting epidermal growth factor receptor in head and neck cancer.

Authors:  Allison Carter Ford; Jennifer Rubin Grandis
Journal:  Head Neck       Date:  2003-01       Impact factor: 3.147

3.  Inverted papilloma and squamous cell carcinoma.

Authors:  K T Yamaguchi; S M Shapshay; J S Incze; C W Vaughan; M S Strong
Journal:  J Otolaryngol       Date:  1979-04

4.  Evaluation of TGF-alpha and EGFR expression in oral leukoplakia and oral submucous fibrosis by quantitative immunohistochemistry.

Authors:  M Srinivasan; S D Jewell
Journal:  Oncology       Date:  2001       Impact factor: 2.935

5.  Downmodulation of TGF-alpha protein expression with antisense oligonucleotides inhibits proliferation of head and neck squamous carcinoma but not normal mucosal epithelial cells.

Authors:  J R Grandis; A Chakraborty; Q Zeng; M F Melhem; D J Tweardy
Journal:  J Cell Biochem       Date:  1998-04-01       Impact factor: 4.429

6.  Epidermal growth factor system regulates mucin production in airways.

Authors:  K Takeyama; K Dabbagh; H M Lee; C Agustí; J A Lausier; I F Ueki; K M Grattan; J A Nadel
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

7.  Dysregulation of epidermal growth factor receptor expression in premalignant lesions during head and neck tumorigenesis.

Authors:  D M Shin; J Y Ro; W K Hong; W N Hittelman
Journal:  Cancer Res       Date:  1994-06-15       Impact factor: 12.701

8.  p53 immunostaining in the differentiation of reactive processes from malignancy in pleural biopsy specimens.

Authors:  P T Cagle; R W Brown; R M Lebovitz
Journal:  Hum Pathol       Date:  1994-05       Impact factor: 3.466

9.  Prognostic significance of epidermal growth factor receptor in squamous cell carcinoma of the maxillary sinus.

Authors:  M Miyaguchi; S Sakai; J Olofsson; H Kuwabara; H Sakamoto
Journal:  Eur Arch Otorhinolaryngol       Date:  1993       Impact factor: 2.503

Review 10.  Oncogenes related to head and neck cancer.

Authors:  W J Issing; T P Wustrow; W J Heppt
Journal:  Anticancer Res       Date:  1993 Nov-Dec       Impact factor: 2.480

View more
  6 in total

Review 1.  Common head and neck cases in our consultation referrals: diagnostic dilemmas in inverted papilloma.

Authors:  Ann Sandison
Journal:  Head Neck Pathol       Date:  2009-08-20

2.  Human papillomavirus infection and biomarkers in sinonasal inverted papillomas: clinical significance and molecular mechanisms.

Authors:  Adam Scheel; Giant C Lin; Jonathan B McHugh; Christine M Komarck; Heather M Walline; Mark E Prince; Mark A Zacharek; Thomas E Carey
Journal:  Int Forum Allergy Rhinol       Date:  2015-06-16       Impact factor: 3.858

3.  Epidermal growth factor receptor, p16, cyclin D1, and p53 staining patterns for inverted papilloma.

Authors:  Giant C Lin; Adam Scheel; Sarah Akkina; Steven Chinn; Martin Graham; Christine Komarck; Heather Walline; Jonathan B McHugh; Mark E Prince; Thomas E Carey; Mark A Zacharek
Journal:  Int Forum Allergy Rhinol       Date:  2013-08-26       Impact factor: 3.858

Review 4.  Risk Factors of Recurrence and Malignant Transformation of Sinonasal Inverted Papilloma.

Authors:  Marta Gamrot-Wrzoł; Paweł Sowa; Grażyna Lisowska; Wojciech Ścierski; Maciej Misiołek
Journal:  Biomed Res Int       Date:  2017-11-09       Impact factor: 3.411

5.  COX-2 Overexpression in Schneiderian Papillomas.

Authors:  Jeffrey D Suh; Kevin Hur; Elisabeth H Ference; David D Lam; Andrew Fong; Adrian J Correa; Bozena Wrobel
Journal:  Allergy Rhinol (Providence)       Date:  2020-12-08

6.  Skull base inverted papilloma: a comprehensive review.

Authors:  Shafik N Wassef; Pete S Batra; Samuel Barnett
Journal:  ISRN Surg       Date:  2012-12-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.